BioSpace News Archive

Unicycive Therapeutics, Inc., a clinical stage biotechnology company developing therapies for patients with kidney disease announced that Keith Ward, Ph.D. has joined Unicycive in the role of Chief Development Officer.

Investigators at Nagourney Cancer Institute will report at the AACR Virtual Annual Meeting, June 22-24, that Alpelisib (BYL 719), an inhibitor of PI3Kα, that was recently approved for ER-Positive breast cancer in combination with Fulvestrant

Medtronic Self-Expanding Venous Stent Demonstrates Favorable Outcomes in Patients with Venous Outflow Obstruction

OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that all the resolutions submitted to a vote at the Combined General Shareholders’ Meeting were approved as proposed by OSE Immunotherapeutics’ Board of Directors.

With a focus on screening local healthcare workers and first responders, the epidemiological study seeks to understand the prevalence of coronavirus infections in the community.

At this year’s cancer congress in Chicago (ASCO), novel hormone treatments of patients suffering from non-metastatic castration-resistant prostate cancer were recognized. There are currently no efficient treatment options for the condition. Prostate cancer is the most common form of cancer in the western world.

Fern Health, a digital health company pioneering virtual musculoskeletal pain programs through employers, today announced the appointment of Hewett Chiu as Chief Operating Officer.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced the presentation of results from the Phase 3 VERTIS CV cardiovascular (CV) outcomes trial that evaluated STEGLATRO (ertugliflozin),

Swittons, a P360 company, today announced that its complete lineup of customizable IoT powered devices now includes integration with Microsoft Teams.

To help ensure a safe and healthy workplace, GeneIQ’s molecular diagnostic laboratory is partnering with Dallas Children’s Advocacy Center (DCAC) as part of the agency’s new protocols for managing the coronavirus pandemic.